EyeOR

 
Home About Testimonials Training Financing Marketing Shop Contact

EyeOR in conjunction with strategic alliances will have multiple options for reaching patient groups.

Comprehensive and New Media Marketing Plans are now available based on your practice's current situation.

Why EyeOR? (pdf)

To learn more click here

Also, be sure to check out our marketing partners at Glacial Multimedia

Marketing

It's just beginning!

There is a pretty strong interest in and trend toward new intraocular refractive procedures being introduced by many new refractive companies. The leading refractive surgeons throughout the country have returned to the operating room to refine their surgical skills in intraocular surgery and have started to offer new approaches to clear lensectomy techniques and strategies for the high hyperopic and now even the mid to high range myopic patients.

The exciting thing is that all these new intraocular procedures will work well in combination with other non-intraocular refractive procedures. The bioptics approach to LASIK and LASEK have already taken center stage at the international refractive seminars over the last few years. New approaches with CK, Crystalens, and other new accommodative techniques and implants will all work in concert with current laser procedures and techniques.

The future is exciting for ophthalmology and we are beginning to witness a blurring between the Medicare and Pre-Medicare patients with these new technologies for multifocal and accommodative targeted results. All this has spurred on numerous market watchers to predict significant growth in the refractive surgery business over the next five to ten years.

Again, the two biggest procedures we see for the in-office approach is in Clearlens (CL) and Phakic IOL procedures. However, when considering the question of whether to invest in your "in-office" operating room?consider how it will interact with your current laser procedures and refractive practice profile. We feel this is the biggest reason and will provide the largest revenue return on investment to the practice.